Neos Therapeutics, Inc. (NEOS) financial statements (2022 and earlier)

Company profile

Business Address 2940 N. HIGHWAY 360
GRAND PRAIRIE, TX 75050
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments24,89446,47850,41739,78290,763
Cash and cash equivalents16,83046,47831,96924,35290,763
Short-term investments8,064 18,44815,430 
Receivables26,56327,80113,6716,1353,903
Inventory, net of allowances, customer advances and progress billings11,01010,36713,4595,7672,520
Inventory11,01010,36713,4595,7672,520
Other current assets 4,0325,0932,8651,058
Other undisclosed current assets4,092  720 
Total current assets:66,55988,67882,64055,26998,244
Noncurrent Assets
Operating lease, right-of-use asset3,044
Property, plant and equipment7,3457,9148,2037,0765,124
Intangible assets, net (including goodwill)12,54314,61616,34815,57916,672
Intangible assets, net (excluding goodwill)12,54314,61616,34815,57916,672
Other noncurrent assets1,3821491622,2182,470
Total noncurrent assets:24,31422,67924,71324,87324,266
TOTAL ASSETS:90,873111,357107,35380,142122,510
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities46,83848,54822,03013,0627,965
Accounts payable6,65012,73011,4607,7984,824
Accrued liabilities40,18835,81810,5705,2643,141
Debt1,5178,5578964,9217,973
Deferred revenue and credits14,6763,662 
Other undisclosed current liabilities15,000    
Total current liabilities:63,35557,10537,60221,64515,938
Noncurrent Liabilities
Long-term debt and lease obligation, including:3,58543,21758,93858,59926,271
Finance lease, liability331
Operating lease, liability3,254
Other undisclosed long-term debt and lease obligation 43,21758,93858,59926,271
Liabilities, other than long-term debt1,2953,1902,9231,4061,380
Deferred revenue and credits1,0831,1741,166
Deferred rent credit 989
Other liabilities160184180  
Business combination, contingent consideration, liability   232214
Derivative instruments and hedges, liabilities1,1352,0171,660  
Other undisclosed noncurrent liabilities28,768  40547
Total noncurrent liabilities:33,64846,40761,86160,04528,198
Total liabilities:97,003103,51299,46381,69044,136
Stockholders' equity
Stockholders' equity attributable to parent(6,130)7,8457,890(1,548)78,374
Common stock5050291616
Treasury stock, value(352)(352)(352)(232)(171)
Additional paid in capital328,056325,130274,584198,787195,314
Accumulated other comprehensive income (loss)1 (6)(1) 
Accumulated deficit(333,885)(316,983)(266,365)(200,118)(116,785)
Total stockholders' equity:(6,130)7,8457,890(1,548)78,374
TOTAL LIABILITIES AND EQUITY:90,873111,357107,35380,142122,510

Income statement (P&L) ($ in thousands)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Revenues64,64949,98825,0189,1543,792
Revenue, net25,0189,1543,792
Cost of revenue
(Cost of Goods and Services Sold)
(25,123)(26,928)(12,391)(11,437)(5,547)
Gross profit:39,52623,06012,627(2,283)(1,755)
Operating expenses(49,941)(66,556)(69,643)(74,123)(24,823)
Operating loss:(10,415)(43,496)(57,016)(76,406)(26,578)
Nonoperating income
(Other Nonoperating income)
1,5337958541,215831
Interest and debt expense(8,009)(8,974) (1,187)(576)
Loss from continuing operations before income taxes:(16,891)(51,675)(56,162)(76,378)(26,323)
Income tax expense(11)    
Loss before gain (loss) on sale of properties:(16,902)(51,675)(56,162)(76,378)(26,323)
Other undisclosed net loss  (10,085)  
Net loss:(16,902)(51,675)(66,247)(76,378)(26,323)
Other undisclosed net loss attributable to parent   (6,955)(4,458)
Net loss attributable to parent:(16,902)(51,675)(66,247)(83,333)(30,781)
Preferred stock dividends and other adjustments    (2,390)
Net loss available to common stockholders, diluted:(16,902)(51,675)(66,247)(83,333)(33,171)

Comprehensive Income ($ in thousands)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Net loss:(16,902)(51,675)(66,247)(76,378)(26,323)
Comprehensive loss:(16,902)(51,675)(66,247)(76,378)(26,323)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent16(5)(6,956) 
Comprehensive loss, net of tax, attributable to parent:(16,901)(51,669)(66,252)(83,334)(26,323)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: